Official 2024 U.S. DOL Form 5500 summary for Galephar Pharmaceutical Research INC (Galephar Pharmaceutical Retirement Plan · EIN 66-0565645 · PN 001): $464,010 net assets, 107 active participants, and $265.46 per $10,000 (265.46 bps).
| Plan Sponsor | Galephar Pharmaceutical Research INC |
|---|---|
| Filing Identifier | Galephar Pharmaceutical Retirement Plan · EIN 66-0565645 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (PR) |
| Asset-Size Peer Cohort | <$1M |
| Plan Net Assets (2024) | $464,010 |
| Active Participants | 107 |
| Direct Admin Fee Rate | $265.46 per $10,000 (265.46 bps) |
| Cohort Peer Median | N/A |
| Primary Recordkeeper / Provider | Empower Retirement |
| Schedule H Line 4a Remittance | Schedule H Line 4a Late Remittance Reported ($21,602, often administrative timing) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI